Clinical Trial Update: A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase II, single-arm, multicenter clinical trial evaluating the perioperative use of sintilimab in patients with resectable locally advanced head and neck squ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: chen chao Professor | Conditions: Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING